NewAmsterdam Pharma (NAMSW) Institutional Ownership $13.78 +0.34 (+2.52%) As of 08/22/2025 03:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for NewAmsterdam Pharma (NASDAQ:NAMSW)Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$597.68KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$34.82K Get NAMSW Insider Trade Alerts Want to know when executives and insiders are buying or selling NewAmsterdam Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NAMSW Institutional Buying and Selling by Quarter NewAmsterdam Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/13/2025 Affinity Asset Advisors LLC245,000$1.96M0.3%+1.3%0.000% 5/14/2025 Affinity Asset Advisors LLC241,957$2.18M0.2%+1.7%0.000% 5/12/2025 Wolverine Asset Management LLC8,884$80K0.0%-30.0%0.000% 2/13/2025 Affinity Asset Advisors LLC237,935$3.33M0.4%+11.7%0.000% 2/3/2025 Wolverine Asset Management LLC12,693$181K0.0%N/A0.000% 7/23/2024 TFC Financial Management Inc.10,000$87K0.0%N/A0.000% 5/15/2024 Affinity Asset Advisors LLC202,599$2.24M0.3%+47.9%0.000% 2/15/2024 Clear Street LLC8,993$28K0.0%-33.2%0.000% 2/14/2024 ADAR1 Capital Management LLC82,857$259K0.1%N/A0.000% 11/15/2023 Affinity Asset Advisors LLC137,000$260K0.1%+270.3%0.000% 8/7/2023 Wolverine Asset Management LLC12,448$26K0.0%N/A0.000% 5/15/2023 Affinity Asset Advisors LLC37,000$68K0.0%N/A0.000% 5/12/2023 Clear Street LLC17,619$32K0.0%N/A0.000% 5/11/2023 Highbridge Capital Management LLC733,327$1.36M0.0%+4.0%0.000% 5/10/2023Exos TFP Holdings LLC93,932$173K0.0%-31.6%0.000% 2/14/2023 RA Capital Management L.P.333,333$289K0.0%N/A0.000% 2/14/2023 EcoR1 Capital LLC66,665$727K0.0%N/A0.000% 2/10/2023Exos TFP Holdings LLC137,317$119K0.0%N/A0.000% 2/3/2023 Frazier Life Sciences Management L.P.500,333$434K0.0%N/A0.000% (Data available from 1/1/2016 forward) NAMSW Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NAMSW shares? During the previous two years, the following institutional investors and hedge funds held shares of NewAmsterdam Pharma shares: Affinity Asset Advisors LLC ($1.96M), ADAR1 Capital Management LLC ($259K), TFC Financial Management Inc. ($87K), and Wolverine Asset Management LLC ($80K), Clear Street LLC ($28K).Learn more on NewAmsterdam Pharma's institutional investors. Which institutional investors have been buying NewAmsterdam Pharma's stock? The following institutional investors have purchased NewAmsterdam Pharma's stock in the last 24 months: Affinity Asset Advisors LLC ($197.63K), ADAR1 Capital Management LLC ($82.86K), Wolverine Asset Management LLC ($12.69K), and TFC Financial Management Inc. ($10K). How much institutional buying is happening at NewAmsterdam Pharma? Institutional investors have bought a total of 44,719 shares in the last 24 months. This purchase volume represents approximately $597.68K in transactions. Which of NewAmsterdam Pharma's major shareholders have been selling company stock? The following institutional investors have sold NewAmsterdam Pharma stock in the last 24 months: Wolverine Asset Management LLC ($3.81K). How much institutional selling is happening at NewAmsterdam Pharma? Institutional investors have sold a total of 3,809 shares in the last 24 months. This volume of shares sold represents approximately $34.82K in transactions. Related Companies Nutriband Major Shareholders This page (NASDAQ:NAMSW) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewAmsterdam Pharma Please log in to your account or sign up in order to add this asset to your watchlist. Share NewAmsterdam Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access